We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Radcal

Download Mobile App




Events

31 Jul 2024 - 02 Aug 2024
02 Aug 2024 - 04 Aug 2024
20 Aug 2024 - 22 Aug 2024

Liver Biopsy Crucial for Reaching Correct Diagnosis, Finds Study

By HospiMedica International staff writers
Posted on 26 Jan 2024
Print article
Image: Liver biopsy illustration (Photo courtesy of NIH)
Image: Liver biopsy illustration (Photo courtesy of NIH)

Biopsies involve collecting tissue samples from the body for detailed analysis, a crucial method for identifying disease markers. For instance, doctors might perform a liver biopsy if there are concerns about a patient's liver health. This procedure involves inserting a needle into the abdomen to remove a small liver tissue sample, which is then examined under a microscope for signs of disease or injury. A biopsy is one of several diagnostic tools for liver disease, alongside imaging and blood tests. However, biopsies come with risks like bleeding and pain, leading some doctors to prefer noninvasive diagnostic methods. Now, a new study suggests that despite the growing popularity of noninvasive options to diagnose liver disease, there are times when more traditional methods like liver biopsy are still needed for a precise diagnosis.

Researchers at the Medical University of South Carolina (Charleston, SC, USA) conducted a study involving 80 patients with various suspected liver conditions. The aim was to assess the biopsy's role in accurate diagnosis. The findings revealed that biopsies played a critical role in correctly diagnosing patients. The initial diagnoses correlated with biopsy results in just under two-thirds of cases, while in over a third of the instances, biopsy was crucial for the right diagnosis. The effectiveness of biopsy varied depending on the disease; autoimmune hepatitis was harder to diagnose without a biopsy, whereas liver fibrosis was correctly identified over two-thirds of the time without a biopsy.

The study also revealed that six out of the 80 participants, initially believed to have liver issues, actually did not have such issues, underscoring the biopsy's value in resolving diagnostic uncertainties. The researchers suggest that patients should advocate for a biopsy when diagnosis is unclear. They are also exploring safer biopsy methods, such as using an endoscope to reduce risk and discomfort, potentially making biopsies more widely available and beneficial.

“Our study shows that that biopsy continues to be valuable as part of our diagnostic arsenal,” said Don Rockey, M.D., hepatologist and researcher at the Medical University of South Carolina. “In the right time, the right place and the right patient, it’s valuable.”

Related Links:
Medical University of South Carolina

Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Silver Member
Wireless Mobile ECG Recorder
NR-1207-3/NR-1207-E
New
Surgical Needle
PORT-JECT

Print article

Channels

Critical Care

view channel
Image: Peerbridge Cor is a 3-lead, 2-channel wireless AECG that simplifies the testing and diagnostic process (Photo courtesy of Peerbridge Health)

First-of-its-Kind Trial to Measure Ejection Fraction Severity Directly from AI-Enabled Remote ECG Wearable

Echocardiograms are a standard diagnostic tool to measure ejection fraction but require a clinical setting for administration. This can pose challenges such as scheduling delays, staffing shortages, accessibility... Read more

Patient Care

view channel
Image: The portable, handheld BeamClean technology inactivates pathogens on commonly touched surfaces in seconds (Photo courtesy of Freestyle Partners)

First-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds

Reducing healthcare-acquired infections (HAIs) remains a pressing issue within global healthcare systems. In the United States alone, 1.7 million patients contract HAIs annually, leading to approximately... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: POCT offers cost-effective, accessible, and immediate diagnostic solutions (Photo courtesy of Flinders University)

POCT for Infectious Diseases Delivers Laboratory Equivalent Pathology Results

On-site pathology tests for infectious diseases in rural and remote locations can achieve the same level of reliability and accuracy as those conducted in hospital laboratories, a recent study suggests.... Read more

Business

view channel
Image: The Innovalve transseptal delivery system is designed to enable safe deployment of the Innovalve implant (Photo courtesy of Innovalve Bio)

Edwards Lifesciences Acquires Sheba Medical’s Innovalve Bio Medical

Edwards Lifesciences (Irvine, CA, USA), a leading company in medical innovations for structural heart disease and critical care, has acquired Innovalve Bio Medical LTD. (Ramat Gan, Israel), an early-stage... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.